Search Results

Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: a nationwide register study.

• Authors : Rådholm K; Division of Community Medicine, Primary Care, Department of Medicine and Health Sciences, Faculty of Health Sciences, Linköping University, Department of Local Care West, County Council of Östergötland, Linköping, Sweden.; Wiréhn AB

Subjects: Antidepressive Agents/Antidepressive Agents/Antidepressive Agents/*adverse effects ; Depression/Depression/Depression/*drug therapy ; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*drug therapy

• Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2016 Feb; Vol. 33 (2), pp. 218-23. Date of Electronic Publication: 2015 Jul 02.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.

• Authors : Chiang CE; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Angiopathies/Diabetic Angiopathies/Diabetic Angiopathies/*drug therapy

• Source: Journal of the Chinese Medical Association : JCMA [J Chin Med Assoc] 2020 Jul; Vol. 83 (7), pp. 587-621.Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

• Authors : Li J; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Renal Section, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.

Subjects: Algorithms*; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*drug therapy

• Source: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2020 Nov 06; Vol. 15 (11), pp. 1678-1688. Date of Electronic Publication: 2020 Jun 09.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?

• Authors : Giugliano D; Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Sciences, Università della Campania L. Vanvitelli, Naples, Italy.; Ceriello A

Subjects: Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/classification ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

• Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Feb; Vol. 22 (2), pp. 149-157. Date of Electronic Publication: 2019 Oct 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제.

• Authors : Kim, Ji Yoon; Kim, Sin Gon

• Source: Journal of Korean Diabetes; Mar2024, Vol. 25 Issue 1, p9-15, 7p

Record details

SGLT-2 Inhibitors in Cancer Treatment—Mechanisms of Action and Emerging New Perspectives.

• Authors : Dutka, Mieczysław; Bobiński, Rafał; Francuz, Tomasz

Subjects: THERAPEUTIC use of antineoplastic agents; IN vitro studies; HYPOGLYCEMIC agents

• Source: Cancers; Dec2022, Vol. 14 Issue 23, p5811, 28p

Record details

The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis.

• Authors : Xu, Chunmei; He, Liping; Zhang, Jing

Subjects: METFORMIN; SODIUM-glucose cotransporters; TYPE 2 diabetes

• Source: Metabolites (2218-1989); Oct2022, Vol. 12 Issue 10, p979-N.PAG, 28p

Record details

Sodium Glucose Cotransporter-2 억제제의 최신지견.

• Authors : 조동혁

• Source: Journal of Korean Diabetes; Jun2021, Vol. 22 Issue 2, p113-125, 13p

Record details

Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation.

• Authors : Soliman, Eman; Essmat, Nariman; Mahmoud, Mona F.

Subjects: HYPOGLYCEMIC agents; OXIDATIVE stress; IMMOBILIZATION stress

• Source: Naunyn-Schmiedeberg's Archives of Pharmacology; Aug2020, Vol. 393 Issue 8, p1391-1404, 14p

Record details

Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors.

• Authors : Packer, Milton

Subjects: HYPOGLYCEMIC agents; SODIUM-glucose cotransporters; NLRP3 protein

• Source: European Journal of Heart Failure; Apr2020, Vol. 22 Issue 4, p618-628, 11p, 1 Diagram, 1 Chart, 2 Graphs

Record details